INHIBITOR THERAPEUTICS INC
Inhibitor Therapeutics Inc is a pharmaceutical company focusing on developing therapies for cancerous and non-cancerous treatments.
INHIBITOR THERAPEUTICS INC
Industry:
Biotechnology Health Care Pharmaceutical Therapeutics
Founded:
1992-01-01
Address:
Tampa, Florida, United States
Country:
United States
Website Url:
http://www.inhibitortx.com
Total Employee:
1+
Status:
Active
Contact:
813.509.2420
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Font Awesome
Official Site Inspections
http://www.inhibitortx.com
- Host name: hwsrv-453764.hostwindsdns.com
- IP address: 23.254.134.180
- Location: Seattle United States
- Latitude: 47.4902
- Longitude: -122.3004
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98168
More informations about "Inhibitor Therapeutics Inc"
Inhibitor Therapeutics | Who We Are
Dec 13, 2022 Our Story Inhibitor Therapeutics, we are a publicly traded, clinical stage pharmaceutical development company. We have a focus on developing and commercializing …See details»
Company Information :: Inhibitor Therapeutics, Inc. (INTI)
Inhibitor Therapeutics is a publicly traded, clinical stage pharmaceutical development company. We have a focus on developing and commercializing innovative therapies, using repurposed, already approved API’s (active …See details»
Inhibitor Therapeutics Inc - Crunchbase Company Profile & Funding
Inhibitor Therapeutics Inc is a pharmaceutical company focusing on developing therapies for cancerous and non-cancerous treatments.See details»
Inhibitor Therapeutics (INTI) Company Profile & Description
May 9, 2025 Company profile for Inhibitor Therapeutics, Inc. (INTI) with a description, list of executives, contact details and other key facts.See details»
Inhibitor Therapeutics | Contact Us
CAUTION NOTICE REGARDING FRAUDULENT RECRUITMENT This is to notify the public that certain unscrupulous persons, purporting to be part of and/or being authorized by the human …See details»
INHIBITOR Therapeutics, Inc. - VentureRadar
"Inhibitor Therapeutics, we are a publicly traded, clinical stage pharmaceutical development company. We have a focus on developing and commercializing innovative therapies, using …See details»
Inhibitor Therapeutics Company Profile - Craft
Inhibitor Therapeutics (formerly known as HedgePath Pharmaceuticals) is a pharmaceutical company focused on developing and commercializing therapies for patients with cancer and …See details»
Board Committees :: Inhibitor Therapeutics, Inc. (INTI)
Overview News & Events Company Info Financial Info Stock Data SEC Filings GovernanceSee details»
Inhibitor Therapeutics, Inc. (INTI)
Inhibitor Therapeutics is a publicly traded, clinical stage pharmaceutical development company. We have a focus on developing and commercializing innovative therapies, using repurposed, …See details»
inhibitortx.com Reviews: Is this site a scam or legit?
Is inhibitortx.com legit or a scam? Read reviews, company details, technical analysis, and more to help you decide if this site is trustworthy or fraudulent.See details»
Inhibitor Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore Inhibitor Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, 9 news, and 6 literature, Disease Domain:Hemic ...See details»
Inhibitor Therapeutics | Pipeline
Inhibitor Therapeutics, Inc. (“INHIBITOR”) is a pharmaceutical development company focused on developing and commercializing innovative therapies based on already approved active …See details»
Inhibitor Therapeutics | Management
Director of Regulatory Affairs AMY MCCORD, PHD Lead authoring and strategy for regulatory dossiers including DMFs, INDs, ANDAs, NDAs, BLAs, MAAs, NDS Provide risk-based …See details»
Corporate Governance :: Inhibitor Therapeutics, Inc. (INTI)
Overview News & Events Company Info Financial Info Stock Data SEC Filings GovernanceSee details»
Press Releases :: Inhibitor Therapeutics, Inc. (INTI)
Oct 31, 2019 INHIBITOR Therapeutics Submits Investigational New Drug Application for Treatment of Patients with Late-Stage Prostate CancerSee details»
Governor Abbott Announces NTxBio Facility In Plano
4 days ago May 14, 2025 | Austin, Texas | Press Release Governor Greg Abbott today announced that NTxBio (“NTx”) will establish a biomanufacturing facility in Plano. The project …See details»
Inhibitor Therapeutics | Board of Directors
MIKE JERMAN Previously a CFO of multiple private equity-backed companies in the energy, SaaS, and manufacturing industries; was a Director with PwC in the US and UK; was a …See details»
Inhibitor Therapeutics | Scientific Advisory Board
The Gorlin Syndrome Alliance (a non-for-profit independent patient advocacy organization) (GSA) conducted an EL-PFDD (externally led patient focused drug development) meeting on October …See details»
Introducing Inhibitor Therapeutics, Inc. New Scientific Advisory …
The Gorlin Syndrome Alliance (a non-for-profit independent patient advocacy organization) (GSA) conducted an EL-PFDD (externally led patient focused drug development) meeting on October …See details»
Inhibitor Therapeutics, Inc. Exclusive License with Johns Hopkins ...
Dec 13, 2023 A critical milestone completed on the mission path of commercializing Itraconazole in numerous oncology indications. TAMPA, Fla., Dec. 13, 2023 /PRNewswire/ -- Inhibitor …See details»